Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis

ClinicalTrials.gov ID: NCT00630656

Public ClinicalTrials.gov record NCT00630656. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study will evaluate the safety and potential benefit of recombinant human talactoferrin as an addition to the standard care of severe sepsis.

Study identification

NCT ID
NCT00630656
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Agennix
Industry
Enrollment
190 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Type not available)
Primary completion
Aug 2009 (Actual)
Completion
Feb 2010 (Actual)
Last update posted
Aug 23, 2011

2008 – 2010

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Loma Linda University Medical Center Loma Linda California 92354 —
UC Davis Medical Center Sacramento California 95817 —
Olive View- UCLA Medical Center Sylmar California 91342 —
Denver Health Medical Center Denver Colorado 80204 —
The George Washington University Hospital Washington D.C. District of Columbia 20037 —
Rush University Medical Center Chicago Illinois 60612 —
West Suburban Medical Center Oak Park Illinois 60302 —
Floyd Memorial Hospital and Health Services New Albany Indiana 47105 —
University of Iowa Hospitals and Clinic Iowa City Iowa 52242 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Baystate Medical Center Springfield Massachusetts 01199 —
Henry Ford Health System Detroit Michigan 48202 —
St. Louis University St Louis Missouri 63110 —
St. John's Mercy Medical Center St Louis Missouri 63141 —
Cooper University Hospital Camden New Jersey 08103 —
Duke University Medical Center Durham North Carolina 27710 —
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27517 —
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 —
University of Pittsburgh Medical Center Presbyterian Hospital Pittsburgh Pennsylvania 15213 —
Rhode Island Hospital Providence Rhode Island 02903 —
Texas Tech University Health Sciences Center El Paso Texas 79905 —
Ben Taub General Hospital Houston Texas 77030 —
The Methodist Hospital Houston Texas 77030 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Scott & White Memorial Hospital Temple Texas 76508 —
Intermountain Medical Center Salt Lake City Utah 84143 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00630656, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2011 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00630656 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →